Skip to main content
logo
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.8590
-0.0210 (-2.39%)
Nov 6, 2026, 4:00 PM EST - Market closed

CytoMed Therapeutics Revenue

CytoMed Therapeutics had revenue of 378.88K SGD in the half year ending June 30, 2026, with 69.00% growth. This brings the company's total for the last twelve months to 789.04K, up 8.11% year-over-year. In the year 2025, CytoMed Therapeutics had annual revenue of 860.85K with 71.02% growth. That makes CytoMed Therapeutics the 44,341st largest company in the world by revenue and 6,277th in the United States.

Revenue (ttm)
789.04K SGD
Revenue Growth
+8.11%
P/S Ratio
16.81
Revenue / Employee
18,787 SGD
Employees
42
Market Cap
10.25M USD

Revenue Chart

Chart
* This company reports financials in SGD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025860.85K357.48K71.02%
Dec 31, 2024503.37K-4.36K-0.86%
Dec 31, 2023507.74K143.82K39.52%
Dec 31, 2022363.91K250.07K219.67%
Dec 31, 2021113.84K54.37K91.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

GDTC News

More News